Corey McCann Healthcare News

This is selected healthcare news for Corey McCann, which is filed under People. There are 104 news items for this page. A press release filter page is also available for Corey McCann.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/24/2022 Is that what Sustainable Earning stands for?: Pear Therapeutics Inc. (PEAR)
... medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at 12:10 p.m. ET. From an analyst's perspective: Pear Therapeutics ...
mzpnews.com
11/21/2022 Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference | Business Wire
... medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at 12:10 p.m. ET. Pear will be available for one-on ...
Business Wire
11/21/2022 Stock Market | FinancialContent Business Page
... medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at 12:10 p.m. ET. Pear will be available for one-on ...
financialcontent.com
11/21/2022 PEAR THERAPEUTICS INC (PEAR) Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference
... medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the Evercore ISI 5th Annual HealthCONx Conference on Wednesday, November 30, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at 12:10 p.m. ET. Pear will be available for one-on ...
researchpool.com
11/15/2022 Pear Therapeutics to Undergo Another Round of Layoffs
... the cuts to reduce operating expenses in 2023. ‚AuPear is making strong and steady progress toward our mission of making PDTs mainstream medicine,‚Au said Corey McCann, MD, PhD, president and CEO of Pear Therapeutics. ‚AuOnce again, we delivered significant quarter-over-quarter revenue growth. We continue to break down ...
MDDI
11/14/2022 Pear Therapeutics Reports Third Quarter 2022 Results
... results for its third quarter ended September 30, 2022. "Pear is making strong and steady progress toward our mission of making PDTs mainstream medicine," said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. "Once again, we delivered significant quarter-over-quarter revenue growth. We continue to ...
Yahoo News
11/10/2022 Stock Market | FinancialContent Business Page
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced management's participation in the virtual BTIG Digital Health Forum being held on Monday, November 21. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat ...
financialcontent.com
11/1/2022 Stock Market | FinancialContent Business Page
... called prescription digital therapeutics (PDTs), today announced the company will participate in the Credit Suisse 31 st Annual Healthcare Conference in Rancho Palos Verdes, California. Corey McCann, M.D., Ph.D., President and CEO, will represent the company in an analyst-led fireside chat at 3:15 p.m. Pacific Time on Tuesday, November ...
financialcontent.com
11/1/2022 Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference
... called prescription digital therapeutics (PDTs), today announced the company will participate in the Credit Suisse 31 st Annual Healthcare Conference in Rancho Palos Verdes, California. Corey McCann, M.D., Ph.D., President and CEO, will represent the company in an analyst-led fireside chat at 3:15 p.m. Pacific Time on Tuesday, November ...
Yahoo News
9/13/2022 Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the LifeSci Partners HealthTech Symposium on September 20, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at ...
inyoregister.com
9/13/2022 2022-09-13 | NDAQ:PEAR | Press Release | Pear Therapeutics Inc.
... commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will participate in the LifeSci Partners HealthTech Symposium on September 20, 2022. Corey McCann, M.D., Ph.D., President and CEO, will participate in a virtual fireside chat at 12:30 p.m. ET. A live audio webcast of the presentation ...
stockhouse.com
9/7/2022 Stock Market | bigspringherald.com
... PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat on Wednesday, September 14 at 2:05 p.m. ET. Pear will be available ...
bigspringherald.com
9/7/2022 PEAR THERAPEUTICS INC (PEAR) Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
... PDTs), today announced the company will participate in the Morgan Stanley 20th Annual Global Healthcare Conference taking place September 12-14, 2022 in New York City. Corey McCann, M.D., Ph.D., President and CEO, will participate in a fireside chat on Wednesday, September 14 at 2:05 p.m. ET. Pear will be available ...
researchpool.com
8/12/2022 Pear Therapeutics Reports Second Quarter 2022 Results | Business
... for its second quarter ended June 30, 2022. ‚AuPear continues to make significant progress in introducing PDTs as an innovative class of medicine,‚Au said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. ‚AuWe believe our evidence generation strategy is demonstrating that our products increase access ...
galvnews.com
8/12/2022 PEAR THERAPEUTICS INC (PEAR) Pear Therapeutics Reports Second Quarter 2022 Results
... for its second quarter ended June 30, 2022. ‚AuPear continues to make significant progress in introducing PDTs as an innovative class of medicine,‚Au said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. ‚AuWe believe our evidence generation strategy is demonstrating that our products increase access ...
researchpool.com
8/12/2022 Pear Therapeutics trims workforce, forecast as state contracts move slower than expected
... from access agreements with state Medicaid plans to offer its app-based addiction treatments, although garnering coverage of its products has been slow going. CEO Corey McCann noted the company is in conversations with more than 30 state Medicaid organizations, some of which are further along. ‚AuThese are states and ...
medtechdive.com
8/11/2022 Pear Therapeutics Reports Second Quarter 2022 Results
... results for its second quarter ended June 30, 2022. "Pear continues to make significant progress in introducing PDTs as an innovative class of medicine," said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. "We believe our evidence generation strategy is demonstrating that our products increase access ...
Yahoo News
8/11/2022 Stock Market | bigspringherald.com
... for its second quarter ended June 30, 2022. ‚AuPear continues to make significant progress in introducing PDTs as an innovative class of medicine,‚Au said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. ‚AuWe believe our evidence generation strategy is demonstrating that our products increase access ...
bigspringherald.com
4/5/2022 Pear Therapeutics to Participate in Upcoming Investor Conferences | Business Wire
... called prescription digital therapeutics (PDTs), today announced management will participate in the following upcoming virtual investor conferences in April 2022. Chardan Prescription Digital Therapeutics Summit. Corey McCann, MD, PhD, President and CEO, will participate in a fireside chat on Monday, April 11 at 1:00 p.m. Eastern Time. A live webcast ...
Business Wire
3/24/2022 Pear Looks to Fruitful Japanese Sleep Market
... the Japanese Association of Preventive Medicine for Adult Disease. "The Japanese market has a large unmet need in treating people with sleep disorders,‚Au said Corey McCann, MD, PhD, president and CEO at Pear. ‚AuThis opportunity fits squarely in our strategy to bring our PDTs to patients around the globe ...
MDDI
3/21/2022 Pear partners to build a digital therapeutic for sleep-wake disorders in Japan
... outside of the United States. The Japanese market has a large unmet need in treating people with sleep disorders," said Pear president and CEO Dr. Corey McCann "This opportunity fits squarely in our strategy to bring our PDTs to patients around the globe." WHY IT MATTERS A study published in ...
MobiHealthNews
3/2/2022 Pear Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference
... prescription digital therapeutics (PDTs), today announced the Company will participate in the 42 nd Annual Cowen Healthcare Conference being held virtually on Wednesday, March 9. Corey McCann, M.D., Ph.D., President and CEO, will represent the Company in an analyst-led fireside chat at 2:50 p.m. Eastern Time. A live audio ...
Business Wire
3/1/2022 Pear's Reimbursement Efforts Bear Fruit
... reimbursement milestone for healthcare providers, payers and patients, and marks another step towards standard of care for coverage and payment for the PDT category," said Corey McCann, MD, PhD, president and CEO of Pear Therapeutics. Pear said it is working with payers to add prescription digital therapeutics as a standard ...
MDDI
2/24/2022 Pear Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapy Inclusive of All of Its Commercial Products | Business Wire
... to describe prescription digital therapeutics and facilitate options for payers to provide access to these treatment options in response to Pear's application,‚Au said Corey McCann, M.D., Ph.D., President and Chief Executive Officer of Pear Therapeutics. ‚AuThis is an important reimbursement milestone for healthcare providers, payers and patients, and ...
Business Wire
2/17/2022 Pear Therapeutics to Participate in Citi's 2022 Virtual Healthcare Conference
... software-based medicines called prescription digital therapeutics (PDTs), today announced the Company will participate in Citi's 2022 Virtual Healthcare Conference on Thursday, February 24. Corey McCann, M.D., Ph.D., President and CEO, will represent the Company in an analyst-led fireside chat at 2:00 p.m. Eastern Time. A live audio ...
Business Wire